Global Heparin Sodium Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Heparin Sodium market size is predicted to grow from US$ 2952 million in 2025 to US$ 4281 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Global Heparin Sodium key players include Shenzhen Hepalink, Bioiberica, Nanjing King-friend, Dongcheng Biochemicals and Changzhou Qianhong Bio-pharma. Global top five manufacturers hold a share about 54%. Europe is the largest market, with a share about 55%, followed by China and North America, with share 22% and 13%, separately. In term of application, the largest application is Low Molecular Weight Heparin Preparations, with a share of 93%.
LP Information, Inc. (LPI) ' newest research report, the “Heparin Sodium Industry Forecast” looks at past sales and reviews total world Heparin Sodium sales in 2024, providing a comprehensive analysis by region and market sector of projected Heparin Sodium sales for 2025 through 2031. With Heparin Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heparin Sodium industry.
This Insight Report provides a comprehensive analysis of the global Heparin Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Heparin Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Heparin Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Heparin Sodium and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Heparin Sodium.
This report presents a comprehensive overview, market shares, and growth opportunities of Heparin Sodium market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Heparin Sodium market?
What factors are driving Heparin Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Heparin Sodium market opportunities vary by end market size?
How does Heparin Sodium break out by Type, by Application?
The global Heparin Sodium market size is predicted to grow from US$ 2952 million in 2025 to US$ 4281 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Global Heparin Sodium key players include Shenzhen Hepalink, Bioiberica, Nanjing King-friend, Dongcheng Biochemicals and Changzhou Qianhong Bio-pharma. Global top five manufacturers hold a share about 54%. Europe is the largest market, with a share about 55%, followed by China and North America, with share 22% and 13%, separately. In term of application, the largest application is Low Molecular Weight Heparin Preparations, with a share of 93%.
LP Information, Inc. (LPI) ' newest research report, the “Heparin Sodium Industry Forecast” looks at past sales and reviews total world Heparin Sodium sales in 2024, providing a comprehensive analysis by region and market sector of projected Heparin Sodium sales for 2025 through 2031. With Heparin Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Heparin Sodium industry.
This Insight Report provides a comprehensive analysis of the global Heparin Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Heparin Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Heparin Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Heparin Sodium and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Heparin Sodium.
This report presents a comprehensive overview, market shares, and growth opportunities of Heparin Sodium market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Type A
- Type B
- Standard Heparin Preparation
- Low Molecular Weight Heparin Preparations
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Shenzhen Hepalink
- Nanjing King-friend
- Bioiberica
- Dongcheng Biochemicals
- Changzhou Qianhong Bio-pharma
- Pfizer
- Changshan Biochemical
- Aspen Oss
- Opocrin
- Qingdao Jiulong Biopharmaceutical
- Yino Pharma Limited
- Dongying Tiandong Pharmaceutical
- Xinbai Pharmaceuticals
- Laboratorios Farmaceuticos ROVI
- Sichuan Deebio
What is the 10-year outlook for the global Heparin Sodium market?
What factors are driving Heparin Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Heparin Sodium market opportunities vary by end market size?
How does Heparin Sodium break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Heparin Sodium Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Heparin Sodium by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Heparin Sodium by Country/Region, 2020, 2024 & 2031
2.2 Heparin Sodium Segment by Type
2.2.1 Type A
2.2.2 Type B
2.3 Heparin Sodium Sales by Type
2.3.1 Global Heparin Sodium Sales Market Share by Type (2020-2025)
2.3.2 Global Heparin Sodium Revenue and Market Share by Type (2020-2025)
2.3.3 Global Heparin Sodium Sale Price by Type (2020-2025)
2.4 Heparin Sodium Segment by Application
2.4.1 Standard Heparin Preparation
2.4.2 Low Molecular Weight Heparin Preparations
2.5 Heparin Sodium Sales by Application
2.5.1 Global Heparin Sodium Sale Market Share by Application (2020-2025)
2.5.2 Global Heparin Sodium Revenue and Market Share by Application (2020-2025)
2.5.3 Global Heparin Sodium Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Heparin Sodium Breakdown Data by Company
3.1.1 Global Heparin Sodium Annual Sales by Company (2020-2025)
3.1.2 Global Heparin Sodium Sales Market Share by Company (2020-2025)
3.2 Global Heparin Sodium Annual Revenue by Company (2020-2025)
3.2.1 Global Heparin Sodium Revenue by Company (2020-2025)
3.2.2 Global Heparin Sodium Revenue Market Share by Company (2020-2025)
3.3 Global Heparin Sodium Sale Price by Company
3.4 Key Manufacturers Heparin Sodium Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heparin Sodium Product Location Distribution
3.4.2 Players Heparin Sodium Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEPARIN SODIUM BY GEOGRAPHIC REGION
4.1 World Historic Heparin Sodium Market Size by Geographic Region (2020-2025)
4.1.1 Global Heparin Sodium Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Heparin Sodium Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Heparin Sodium Market Size by Country/Region (2020-2025)
4.2.1 Global Heparin Sodium Annual Sales by Country/Region (2020-2025)
4.2.2 Global Heparin Sodium Annual Revenue by Country/Region (2020-2025)
4.3 Americas Heparin Sodium Sales Growth
4.4 APAC Heparin Sodium Sales Growth
4.5 Europe Heparin Sodium Sales Growth
4.6 Middle East & Africa Heparin Sodium Sales Growth
5 AMERICAS
5.1 Americas Heparin Sodium Sales by Country
5.1.1 Americas Heparin Sodium Sales by Country (2020-2025)
5.1.2 Americas Heparin Sodium Revenue by Country (2020-2025)
5.2 Americas Heparin Sodium Sales by Type (2020-2025)
5.3 Americas Heparin Sodium Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heparin Sodium Sales by Region
6.1.1 APAC Heparin Sodium Sales by Region (2020-2025)
6.1.2 APAC Heparin Sodium Revenue by Region (2020-2025)
6.2 APAC Heparin Sodium Sales by Type (2020-2025)
6.3 APAC Heparin Sodium Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Heparin Sodium by Country
7.1.1 Europe Heparin Sodium Sales by Country (2020-2025)
7.1.2 Europe Heparin Sodium Revenue by Country (2020-2025)
7.2 Europe Heparin Sodium Sales by Type (2020-2025)
7.3 Europe Heparin Sodium Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Heparin Sodium by Country
8.1.1 Middle East & Africa Heparin Sodium Sales by Country (2020-2025)
8.1.2 Middle East & Africa Heparin Sodium Revenue by Country (2020-2025)
8.2 Middle East & Africa Heparin Sodium Sales by Type (2020-2025)
8.3 Middle East & Africa Heparin Sodium Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Heparin Sodium
10.3 Manufacturing Process Analysis of Heparin Sodium
10.4 Industry Chain Structure of Heparin Sodium
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Heparin Sodium Distributors
11.3 Heparin Sodium Customer
12 WORLD FORECAST REVIEW FOR HEPARIN SODIUM BY GEOGRAPHIC REGION
12.1 Global Heparin Sodium Market Size Forecast by Region
12.1.1 Global Heparin Sodium Forecast by Region (2026-2031)
12.1.2 Global Heparin Sodium Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Heparin Sodium Forecast by Type (2026-2031)
12.7 Global Heparin Sodium Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Shenzhen Hepalink
13.1.1 Shenzhen Hepalink Company Information
13.1.2 Shenzhen Hepalink Heparin Sodium Product Portfolios and Specifications
13.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Shenzhen Hepalink Main Business Overview
13.1.5 Shenzhen Hepalink Latest Developments
13.2 Nanjing King-friend
13.2.1 Nanjing King-friend Company Information
13.2.2 Nanjing King-friend Heparin Sodium Product Portfolios and Specifications
13.2.3 Nanjing King-friend Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Nanjing King-friend Main Business Overview
13.2.5 Nanjing King-friend Latest Developments
13.3 Bioiberica
13.3.1 Bioiberica Company Information
13.3.2 Bioiberica Heparin Sodium Product Portfolios and Specifications
13.3.3 Bioiberica Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bioiberica Main Business Overview
13.3.5 Bioiberica Latest Developments
13.4 Dongcheng Biochemicals
13.4.1 Dongcheng Biochemicals Company Information
13.4.2 Dongcheng Biochemicals Heparin Sodium Product Portfolios and Specifications
13.4.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Dongcheng Biochemicals Main Business Overview
13.4.5 Dongcheng Biochemicals Latest Developments
13.5 Changzhou Qianhong Bio-pharma
13.5.1 Changzhou Qianhong Bio-pharma Company Information
13.5.2 Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolios and Specifications
13.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Changzhou Qianhong Bio-pharma Main Business Overview
13.5.5 Changzhou Qianhong Bio-pharma Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Heparin Sodium Product Portfolios and Specifications
13.6.3 Pfizer Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Changshan Biochemical
13.7.1 Changshan Biochemical Company Information
13.7.2 Changshan Biochemical Heparin Sodium Product Portfolios and Specifications
13.7.3 Changshan Biochemical Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Changshan Biochemical Main Business Overview
13.7.5 Changshan Biochemical Latest Developments
13.8 Aspen Oss
13.8.1 Aspen Oss Company Information
13.8.2 Aspen Oss Heparin Sodium Product Portfolios and Specifications
13.8.3 Aspen Oss Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Aspen Oss Main Business Overview
13.8.5 Aspen Oss Latest Developments
13.9 Opocrin
13.9.1 Opocrin Company Information
13.9.2 Opocrin Heparin Sodium Product Portfolios and Specifications
13.9.3 Opocrin Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Opocrin Main Business Overview
13.9.5 Opocrin Latest Developments
13.10 Qingdao Jiulong Biopharmaceutical
13.10.1 Qingdao Jiulong Biopharmaceutical Company Information
13.10.2 Qingdao Jiulong Biopharmaceutical Heparin Sodium Product Portfolios and Specifications
13.10.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Qingdao Jiulong Biopharmaceutical Main Business Overview
13.10.5 Qingdao Jiulong Biopharmaceutical Latest Developments
13.11 Yino Pharma Limited
13.11.1 Yino Pharma Limited Company Information
13.11.2 Yino Pharma Limited Heparin Sodium Product Portfolios and Specifications
13.11.3 Yino Pharma Limited Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Yino Pharma Limited Main Business Overview
13.11.5 Yino Pharma Limited Latest Developments
13.12 Dongying Tiandong Pharmaceutical
13.12.1 Dongying Tiandong Pharmaceutical Company Information
13.12.2 Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolios and Specifications
13.12.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Dongying Tiandong Pharmaceutical Main Business Overview
13.12.5 Dongying Tiandong Pharmaceutical Latest Developments
13.13 Xinbai Pharmaceuticals
13.13.1 Xinbai Pharmaceuticals Company Information
13.13.2 Xinbai Pharmaceuticals Heparin Sodium Product Portfolios and Specifications
13.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Xinbai Pharmaceuticals Main Business Overview
13.13.5 Xinbai Pharmaceuticals Latest Developments
13.14 Laboratorios Farmaceuticos ROVI
13.14.1 Laboratorios Farmaceuticos ROVI Company Information
13.14.2 Laboratorios Farmaceuticos ROVI Heparin Sodium Product Portfolios and Specifications
13.14.3 Laboratorios Farmaceuticos ROVI Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Laboratorios Farmaceuticos ROVI Main Business Overview
13.14.5 Laboratorios Farmaceuticos ROVI Latest Developments
13.15 Sichuan Deebio
13.15.1 Sichuan Deebio Company Information
13.15.2 Sichuan Deebio Heparin Sodium Product Portfolios and Specifications
13.15.3 Sichuan Deebio Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sichuan Deebio Main Business Overview
13.15.5 Sichuan Deebio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Heparin Sodium Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Heparin Sodium Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofType A
Table 4. Major Players ofType B
Table 5. Global Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 6. Global Heparin Sodium Sales Market Share byType (2020-2025)
Table 7. Global Heparin Sodium Revenue byType (2020-2025) & ($ million)
Table 8. Global Heparin Sodium Revenue Market Share byType (2020-2025)
Table 9. Global Heparin Sodium Sale Price byType (2020-2025) & (USD/Million Units)
Table 10. Global Heparin Sodium Sale by Application (2020-2025) & (Million Units)
Table 11. Global Heparin Sodium Sale Market Share by Application (2020-2025)
Table 12. Global Heparin Sodium Revenue by Application (2020-2025) & ($ million)
Table 13. Global Heparin Sodium Revenue Market Share by Application (2020-2025)
Table 14. Global Heparin Sodium Sale Price by Application (2020-2025) & (USD/Million Units)
Table 15. Global Heparin Sodium Sales by Company (2020-2025) & (Million Units)
Table 16. Global Heparin Sodium Sales Market Share by Company (2020-2025)
Table 17. Global Heparin Sodium Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Heparin Sodium Revenue Market Share by Company (2020-2025)
Table 19. Global Heparin Sodium Sale Price by Company (2020-2025) & (USD/Million Units)
Table 20. Key Manufacturers Heparin Sodium Producing Area Distribution and Sales Area
Table 21. Players Heparin Sodium Products Offered
Table 22. Heparin Sodium Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Heparin Sodium Sales by Geographic Region (2020-2025) & (Million Units)
Table 26. Global Heparin Sodium Sales Market Share Geographic Region (2020-2025)
Table 27. Global Heparin Sodium Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Heparin Sodium Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Heparin Sodium Sales by Country/Region (2020-2025) & (Million Units)
Table 30. Global Heparin Sodium Sales Market Share by Country/Region (2020-2025)
Table 31. Global Heparin Sodium Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Heparin Sodium Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 34. Americas Heparin Sodium Sales Market Share by Country (2020-2025)
Table 35. Americas Heparin Sodium Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 37. Americas Heparin Sodium Sales by Application (2020-2025) & (Million Units)
Table 38. APAC Heparin Sodium Sales by Region (2020-2025) & (Million Units)
Table 39. APAC Heparin Sodium Sales Market Share by Region (2020-2025)
Table 40. APAC Heparin Sodium Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 42. APAC Heparin Sodium Sales by Application (2020-2025) & (Million Units)
Table 43. Europe Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 44. Europe Heparin Sodium Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 46. Europe Heparin Sodium Sales by Application (2020-2025) & (Million Units)
Table 47. Middle East & Africa Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 48. Middle East & Africa Heparin Sodium Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 50. Middle East & Africa Heparin Sodium Sales by Application (2020-2025) & (Million Units)
Table 51. Key Market Drivers & Growth Opportunities of Heparin Sodium
Table 52. Key Market Challenges & Risks of Heparin Sodium
Table 53. Key IndustryTrends of Heparin Sodium
Table 54. Heparin Sodium Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Heparin Sodium Distributors List
Table 57. Heparin Sodium Customer List
Table 58. Global Heparin Sodium SalesForecast by Region (2026-2031) & (Million Units)
Table 59. Global Heparin Sodium RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Heparin Sodium SalesForecast by Country (2026-2031) & (Million Units)
Table 61. Americas Heparin Sodium Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Heparin Sodium SalesForecast by Region (2026-2031) & (Million Units)
Table 63. APAC Heparin Sodium Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Heparin Sodium SalesForecast by Country (2026-2031) & (Million Units)
Table 65. Europe Heparin Sodium RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Heparin Sodium SalesForecast by Country (2026-2031) & (Million Units)
Table 67. Middle East & Africa Heparin Sodium RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Heparin Sodium SalesForecast byType (2026-2031) & (Million Units)
Table 69. Global Heparin Sodium RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Heparin Sodium SalesForecast by Application (2026-2031) & (Million Units)
Table 71. Global Heparin Sodium RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Shenzhen Hepalink Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 73. Shenzhen Hepalink Heparin Sodium Product Portfolios and Specifications
Table 74. Shenzhen Hepalink Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 75. Shenzhen Hepalink Main Business
Table 76. Shenzhen Hepalink Latest Developments
Table 77. Nanjing King-friend Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 78. Nanjing King-friend Heparin Sodium Product Portfolios and Specifications
Table 79. Nanjing King-friend Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 80. Nanjing King-friend Main Business
Table 81. Nanjing King-friend Latest Developments
Table 82. Bioiberica Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 83. Bioiberica Heparin Sodium Product Portfolios and Specifications
Table 84. Bioiberica Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 85. Bioiberica Main Business
Table 86. Bioiberica Latest Developments
Table 87. Dongcheng Biochemicals Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 88. Dongcheng Biochemicals Heparin Sodium Product Portfolios and Specifications
Table 89. Dongcheng Biochemicals Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 90. Dongcheng Biochemicals Main Business
Table 91. Dongcheng Biochemicals Latest Developments
Table 92. Changzhou Qianhong Bio-pharma Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 93. Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolios and Specifications
Table 94. Changzhou Qianhong Bio-pharma Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 95. Changzhou Qianhong Bio-pharma Main Business
Table 96. Changzhou Qianhong Bio-pharma Latest Developments
Table 97. Pfizer Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Heparin Sodium Product Portfolios and Specifications
Table 99. Pfizer Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments
Table 102. Changshan Biochemical Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 103. Changshan Biochemical Heparin Sodium Product Portfolios and Specifications
Table 104. Changshan Biochemical Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 105. Changshan Biochemical Main Business
Table 106. Changshan Biochemical Latest Developments
Table 107. Aspen Oss Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 108. Aspen Oss Heparin Sodium Product Portfolios and Specifications
Table 109. Aspen Oss Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 110. Aspen Oss Main Business
Table 111. Aspen Oss Latest Developments
Table 112. Opocrin Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 113. Opocrin Heparin Sodium Product Portfolios and Specifications
Table 114. Opocrin Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 115. Opocrin Main Business
Table 116. Opocrin Latest Developments
Table 117. Qingdao Jiulong Biopharmaceutical Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 118. Qingdao Jiulong Biopharmaceutical Heparin Sodium Product Portfolios and Specifications
Table 119. Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 120. Qingdao Jiulong Biopharmaceutical Main Business
Table 121. Qingdao Jiulong Biopharmaceutical Latest Developments
Table 122. Yino Pharma Limited Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 123. Yino Pharma Limited Heparin Sodium Product Portfolios and Specifications
Table 124. Yino Pharma Limited Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 125. Yino Pharma Limited Main Business
Table 126. Yino Pharma Limited Latest Developments
Table 127. DongyingTiandong Pharmaceutical Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 128. DongyingTiandong Pharmaceutical Heparin Sodium Product Portfolios and Specifications
Table 129. DongyingTiandong Pharmaceutical Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 130. DongyingTiandong Pharmaceutical Main Business
Table 131. DongyingTiandong Pharmaceutical Latest Developments
Table 132. Xinbai Pharmaceuticals Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 133. Xinbai Pharmaceuticals Heparin Sodium Product Portfolios and Specifications
Table 134. Xinbai Pharmaceuticals Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 135. Xinbai Pharmaceuticals Main Business
Table 136. Xinbai Pharmaceuticals Latest Developments
Table 137. LaboratoriosFarmaceuticos ROVI Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 138. LaboratoriosFarmaceuticos ROVI Heparin Sodium Product Portfolios and Specifications
Table 139. LaboratoriosFarmaceuticos ROVI Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 140. LaboratoriosFarmaceuticos ROVI Main Business
Table 141. LaboratoriosFarmaceuticos ROVI Latest Developments
Table 142. Sichuan Deebio Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 143. Sichuan Deebio Heparin Sodium Product Portfolios and Specifications
Table 144. Sichuan Deebio Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 145. Sichuan Deebio Main Business
Table 146. Sichuan Deebio Latest Developments
LIST OFFIGURES
Figure 1. Picture of Heparin Sodium
Figure 2. Heparin Sodium Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Heparin Sodium Sales Growth Rate 2020-2031 (Million Units)
Figure 7. Global Heparin Sodium Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Heparin Sodium Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Heparin Sodium Sales Market Share by Country/Region (2024)
Figure 10. Heparin Sodium Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofType A
Figure 12. Product Picture ofType B
Figure 13. Global Heparin Sodium Sales Market Share byType in 2025
Figure 14. Global Heparin Sodium Revenue Market Share byType (2020-2025)
Figure 15. Heparin Sodium Consumed in Standard Heparin Preparation
Figure 16. Global Heparin Sodium Market: Standard Heparin Preparation (2020-2025) & (Million Units)
Figure 17. Heparin Sodium Consumed in Low Molecular Weight Heparin Preparations
Figure 18. Global Heparin Sodium Market: Low Molecular Weight Heparin Preparations (2020-2025) & (Million Units)
Figure 19. Global Heparin Sodium Sale Market Share by Application (2024)
Figure 20. Global Heparin Sodium Revenue Market Share by Application in 2025
Figure 21. Heparin Sodium Sales by Company in 2025 (Million Units)
Figure 22. Global Heparin Sodium Sales Market Share by Company in 2025
Figure 23. Heparin Sodium Revenue by Company in 2025 ($ millions)
Figure 24. Global Heparin Sodium Revenue Market Share by Company in 2025
Figure 25. Global Heparin Sodium Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Heparin Sodium Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Heparin Sodium Sales 2020-2025 (Million Units)
Figure 28. Americas Heparin Sodium Revenue 2020-2025 ($ millions)
Figure 29. APAC Heparin Sodium Sales 2020-2025 (Million Units)
Figure 30. APAC Heparin Sodium Revenue 2020-2025 ($ millions)
Figure 31. Europe Heparin Sodium Sales 2020-2025 (Million Units)
Figure 32. Europe Heparin Sodium Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Heparin Sodium Sales 2020-2025 (Million Units)
Figure 34. Middle East & Africa Heparin Sodium Revenue 2020-2025 ($ millions)
Figure 35. Americas Heparin Sodium Sales Market Share by Country in 2025
Figure 36. Americas Heparin Sodium Revenue Market Share by Country (2020-2025)
Figure 37. Americas Heparin Sodium Sales Market Share byType (2020-2025)
Figure 38. Americas Heparin Sodium Sales Market Share by Application (2020-2025)
Figure 39. United States Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Heparin Sodium Sales Market Share by Region in 2025
Figure 44. APAC Heparin Sodium Revenue Market Share by Region (2020-2025)
Figure 45. APAC Heparin Sodium Sales Market Share byType (2020-2025)
Figure 46. APAC Heparin Sodium Sales Market Share by Application (2020-2025)
Figure 47. China Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 51. India Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Heparin Sodium Sales Market Share by Country in 2025
Figure 55. Europe Heparin Sodium Revenue Market Share by Country (2020-2025)
Figure 56. Europe Heparin Sodium Sales Market Share byType (2020-2025)
Figure 57. Europe Heparin Sodium Sales Market Share by Application (2020-2025)
Figure 58. Germany Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 59.France Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Heparin Sodium Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Heparin Sodium Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Heparin Sodium Sales Market Share by Application (2020-2025)
Figure 66. Egypt Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Heparin Sodium in 2025
Figure 72. Manufacturing Process Analysis of Heparin Sodium
Figure 73. Industry Chain Structure of Heparin Sodium
Figure 74. Channels of Distribution
Figure 75. Global Heparin Sodium Sales MarketForecast by Region (2026-2031)
Figure 76. Global Heparin Sodium Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Heparin Sodium Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Heparin Sodium Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Heparin Sodium Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Heparin Sodium Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Heparin Sodium Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Heparin Sodium by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Heparin Sodium by Country/Region, 2020, 2024 & 2031
2.2 Heparin Sodium Segment by Type
2.2.1 Type A
2.2.2 Type B
2.3 Heparin Sodium Sales by Type
2.3.1 Global Heparin Sodium Sales Market Share by Type (2020-2025)
2.3.2 Global Heparin Sodium Revenue and Market Share by Type (2020-2025)
2.3.3 Global Heparin Sodium Sale Price by Type (2020-2025)
2.4 Heparin Sodium Segment by Application
2.4.1 Standard Heparin Preparation
2.4.2 Low Molecular Weight Heparin Preparations
2.5 Heparin Sodium Sales by Application
2.5.1 Global Heparin Sodium Sale Market Share by Application (2020-2025)
2.5.2 Global Heparin Sodium Revenue and Market Share by Application (2020-2025)
2.5.3 Global Heparin Sodium Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Heparin Sodium Breakdown Data by Company
3.1.1 Global Heparin Sodium Annual Sales by Company (2020-2025)
3.1.2 Global Heparin Sodium Sales Market Share by Company (2020-2025)
3.2 Global Heparin Sodium Annual Revenue by Company (2020-2025)
3.2.1 Global Heparin Sodium Revenue by Company (2020-2025)
3.2.2 Global Heparin Sodium Revenue Market Share by Company (2020-2025)
3.3 Global Heparin Sodium Sale Price by Company
3.4 Key Manufacturers Heparin Sodium Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heparin Sodium Product Location Distribution
3.4.2 Players Heparin Sodium Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEPARIN SODIUM BY GEOGRAPHIC REGION
4.1 World Historic Heparin Sodium Market Size by Geographic Region (2020-2025)
4.1.1 Global Heparin Sodium Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Heparin Sodium Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Heparin Sodium Market Size by Country/Region (2020-2025)
4.2.1 Global Heparin Sodium Annual Sales by Country/Region (2020-2025)
4.2.2 Global Heparin Sodium Annual Revenue by Country/Region (2020-2025)
4.3 Americas Heparin Sodium Sales Growth
4.4 APAC Heparin Sodium Sales Growth
4.5 Europe Heparin Sodium Sales Growth
4.6 Middle East & Africa Heparin Sodium Sales Growth
5 AMERICAS
5.1 Americas Heparin Sodium Sales by Country
5.1.1 Americas Heparin Sodium Sales by Country (2020-2025)
5.1.2 Americas Heparin Sodium Revenue by Country (2020-2025)
5.2 Americas Heparin Sodium Sales by Type (2020-2025)
5.3 Americas Heparin Sodium Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heparin Sodium Sales by Region
6.1.1 APAC Heparin Sodium Sales by Region (2020-2025)
6.1.2 APAC Heparin Sodium Revenue by Region (2020-2025)
6.2 APAC Heparin Sodium Sales by Type (2020-2025)
6.3 APAC Heparin Sodium Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Heparin Sodium by Country
7.1.1 Europe Heparin Sodium Sales by Country (2020-2025)
7.1.2 Europe Heparin Sodium Revenue by Country (2020-2025)
7.2 Europe Heparin Sodium Sales by Type (2020-2025)
7.3 Europe Heparin Sodium Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Heparin Sodium by Country
8.1.1 Middle East & Africa Heparin Sodium Sales by Country (2020-2025)
8.1.2 Middle East & Africa Heparin Sodium Revenue by Country (2020-2025)
8.2 Middle East & Africa Heparin Sodium Sales by Type (2020-2025)
8.3 Middle East & Africa Heparin Sodium Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Heparin Sodium
10.3 Manufacturing Process Analysis of Heparin Sodium
10.4 Industry Chain Structure of Heparin Sodium
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Heparin Sodium Distributors
11.3 Heparin Sodium Customer
12 WORLD FORECAST REVIEW FOR HEPARIN SODIUM BY GEOGRAPHIC REGION
12.1 Global Heparin Sodium Market Size Forecast by Region
12.1.1 Global Heparin Sodium Forecast by Region (2026-2031)
12.1.2 Global Heparin Sodium Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Heparin Sodium Forecast by Type (2026-2031)
12.7 Global Heparin Sodium Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Shenzhen Hepalink
13.1.1 Shenzhen Hepalink Company Information
13.1.2 Shenzhen Hepalink Heparin Sodium Product Portfolios and Specifications
13.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Shenzhen Hepalink Main Business Overview
13.1.5 Shenzhen Hepalink Latest Developments
13.2 Nanjing King-friend
13.2.1 Nanjing King-friend Company Information
13.2.2 Nanjing King-friend Heparin Sodium Product Portfolios and Specifications
13.2.3 Nanjing King-friend Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Nanjing King-friend Main Business Overview
13.2.5 Nanjing King-friend Latest Developments
13.3 Bioiberica
13.3.1 Bioiberica Company Information
13.3.2 Bioiberica Heparin Sodium Product Portfolios and Specifications
13.3.3 Bioiberica Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bioiberica Main Business Overview
13.3.5 Bioiberica Latest Developments
13.4 Dongcheng Biochemicals
13.4.1 Dongcheng Biochemicals Company Information
13.4.2 Dongcheng Biochemicals Heparin Sodium Product Portfolios and Specifications
13.4.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Dongcheng Biochemicals Main Business Overview
13.4.5 Dongcheng Biochemicals Latest Developments
13.5 Changzhou Qianhong Bio-pharma
13.5.1 Changzhou Qianhong Bio-pharma Company Information
13.5.2 Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolios and Specifications
13.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Changzhou Qianhong Bio-pharma Main Business Overview
13.5.5 Changzhou Qianhong Bio-pharma Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Heparin Sodium Product Portfolios and Specifications
13.6.3 Pfizer Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Changshan Biochemical
13.7.1 Changshan Biochemical Company Information
13.7.2 Changshan Biochemical Heparin Sodium Product Portfolios and Specifications
13.7.3 Changshan Biochemical Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Changshan Biochemical Main Business Overview
13.7.5 Changshan Biochemical Latest Developments
13.8 Aspen Oss
13.8.1 Aspen Oss Company Information
13.8.2 Aspen Oss Heparin Sodium Product Portfolios and Specifications
13.8.3 Aspen Oss Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Aspen Oss Main Business Overview
13.8.5 Aspen Oss Latest Developments
13.9 Opocrin
13.9.1 Opocrin Company Information
13.9.2 Opocrin Heparin Sodium Product Portfolios and Specifications
13.9.3 Opocrin Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Opocrin Main Business Overview
13.9.5 Opocrin Latest Developments
13.10 Qingdao Jiulong Biopharmaceutical
13.10.1 Qingdao Jiulong Biopharmaceutical Company Information
13.10.2 Qingdao Jiulong Biopharmaceutical Heparin Sodium Product Portfolios and Specifications
13.10.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Qingdao Jiulong Biopharmaceutical Main Business Overview
13.10.5 Qingdao Jiulong Biopharmaceutical Latest Developments
13.11 Yino Pharma Limited
13.11.1 Yino Pharma Limited Company Information
13.11.2 Yino Pharma Limited Heparin Sodium Product Portfolios and Specifications
13.11.3 Yino Pharma Limited Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Yino Pharma Limited Main Business Overview
13.11.5 Yino Pharma Limited Latest Developments
13.12 Dongying Tiandong Pharmaceutical
13.12.1 Dongying Tiandong Pharmaceutical Company Information
13.12.2 Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolios and Specifications
13.12.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Dongying Tiandong Pharmaceutical Main Business Overview
13.12.5 Dongying Tiandong Pharmaceutical Latest Developments
13.13 Xinbai Pharmaceuticals
13.13.1 Xinbai Pharmaceuticals Company Information
13.13.2 Xinbai Pharmaceuticals Heparin Sodium Product Portfolios and Specifications
13.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Xinbai Pharmaceuticals Main Business Overview
13.13.5 Xinbai Pharmaceuticals Latest Developments
13.14 Laboratorios Farmaceuticos ROVI
13.14.1 Laboratorios Farmaceuticos ROVI Company Information
13.14.2 Laboratorios Farmaceuticos ROVI Heparin Sodium Product Portfolios and Specifications
13.14.3 Laboratorios Farmaceuticos ROVI Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Laboratorios Farmaceuticos ROVI Main Business Overview
13.14.5 Laboratorios Farmaceuticos ROVI Latest Developments
13.15 Sichuan Deebio
13.15.1 Sichuan Deebio Company Information
13.15.2 Sichuan Deebio Heparin Sodium Product Portfolios and Specifications
13.15.3 Sichuan Deebio Heparin Sodium Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sichuan Deebio Main Business Overview
13.15.5 Sichuan Deebio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Heparin Sodium Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Heparin Sodium Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofType A
Table 4. Major Players ofType B
Table 5. Global Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 6. Global Heparin Sodium Sales Market Share byType (2020-2025)
Table 7. Global Heparin Sodium Revenue byType (2020-2025) & ($ million)
Table 8. Global Heparin Sodium Revenue Market Share byType (2020-2025)
Table 9. Global Heparin Sodium Sale Price byType (2020-2025) & (USD/Million Units)
Table 10. Global Heparin Sodium Sale by Application (2020-2025) & (Million Units)
Table 11. Global Heparin Sodium Sale Market Share by Application (2020-2025)
Table 12. Global Heparin Sodium Revenue by Application (2020-2025) & ($ million)
Table 13. Global Heparin Sodium Revenue Market Share by Application (2020-2025)
Table 14. Global Heparin Sodium Sale Price by Application (2020-2025) & (USD/Million Units)
Table 15. Global Heparin Sodium Sales by Company (2020-2025) & (Million Units)
Table 16. Global Heparin Sodium Sales Market Share by Company (2020-2025)
Table 17. Global Heparin Sodium Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Heparin Sodium Revenue Market Share by Company (2020-2025)
Table 19. Global Heparin Sodium Sale Price by Company (2020-2025) & (USD/Million Units)
Table 20. Key Manufacturers Heparin Sodium Producing Area Distribution and Sales Area
Table 21. Players Heparin Sodium Products Offered
Table 22. Heparin Sodium Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Heparin Sodium Sales by Geographic Region (2020-2025) & (Million Units)
Table 26. Global Heparin Sodium Sales Market Share Geographic Region (2020-2025)
Table 27. Global Heparin Sodium Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Heparin Sodium Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Heparin Sodium Sales by Country/Region (2020-2025) & (Million Units)
Table 30. Global Heparin Sodium Sales Market Share by Country/Region (2020-2025)
Table 31. Global Heparin Sodium Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Heparin Sodium Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 34. Americas Heparin Sodium Sales Market Share by Country (2020-2025)
Table 35. Americas Heparin Sodium Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 37. Americas Heparin Sodium Sales by Application (2020-2025) & (Million Units)
Table 38. APAC Heparin Sodium Sales by Region (2020-2025) & (Million Units)
Table 39. APAC Heparin Sodium Sales Market Share by Region (2020-2025)
Table 40. APAC Heparin Sodium Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 42. APAC Heparin Sodium Sales by Application (2020-2025) & (Million Units)
Table 43. Europe Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 44. Europe Heparin Sodium Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 46. Europe Heparin Sodium Sales by Application (2020-2025) & (Million Units)
Table 47. Middle East & Africa Heparin Sodium Sales by Country (2020-2025) & (Million Units)
Table 48. Middle East & Africa Heparin Sodium Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Heparin Sodium Sales byType (2020-2025) & (Million Units)
Table 50. Middle East & Africa Heparin Sodium Sales by Application (2020-2025) & (Million Units)
Table 51. Key Market Drivers & Growth Opportunities of Heparin Sodium
Table 52. Key Market Challenges & Risks of Heparin Sodium
Table 53. Key IndustryTrends of Heparin Sodium
Table 54. Heparin Sodium Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Heparin Sodium Distributors List
Table 57. Heparin Sodium Customer List
Table 58. Global Heparin Sodium SalesForecast by Region (2026-2031) & (Million Units)
Table 59. Global Heparin Sodium RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Heparin Sodium SalesForecast by Country (2026-2031) & (Million Units)
Table 61. Americas Heparin Sodium Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Heparin Sodium SalesForecast by Region (2026-2031) & (Million Units)
Table 63. APAC Heparin Sodium Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Heparin Sodium SalesForecast by Country (2026-2031) & (Million Units)
Table 65. Europe Heparin Sodium RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Heparin Sodium SalesForecast by Country (2026-2031) & (Million Units)
Table 67. Middle East & Africa Heparin Sodium RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Heparin Sodium SalesForecast byType (2026-2031) & (Million Units)
Table 69. Global Heparin Sodium RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Heparin Sodium SalesForecast by Application (2026-2031) & (Million Units)
Table 71. Global Heparin Sodium RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Shenzhen Hepalink Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 73. Shenzhen Hepalink Heparin Sodium Product Portfolios and Specifications
Table 74. Shenzhen Hepalink Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 75. Shenzhen Hepalink Main Business
Table 76. Shenzhen Hepalink Latest Developments
Table 77. Nanjing King-friend Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 78. Nanjing King-friend Heparin Sodium Product Portfolios and Specifications
Table 79. Nanjing King-friend Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 80. Nanjing King-friend Main Business
Table 81. Nanjing King-friend Latest Developments
Table 82. Bioiberica Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 83. Bioiberica Heparin Sodium Product Portfolios and Specifications
Table 84. Bioiberica Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 85. Bioiberica Main Business
Table 86. Bioiberica Latest Developments
Table 87. Dongcheng Biochemicals Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 88. Dongcheng Biochemicals Heparin Sodium Product Portfolios and Specifications
Table 89. Dongcheng Biochemicals Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 90. Dongcheng Biochemicals Main Business
Table 91. Dongcheng Biochemicals Latest Developments
Table 92. Changzhou Qianhong Bio-pharma Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 93. Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolios and Specifications
Table 94. Changzhou Qianhong Bio-pharma Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 95. Changzhou Qianhong Bio-pharma Main Business
Table 96. Changzhou Qianhong Bio-pharma Latest Developments
Table 97. Pfizer Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 98. Pfizer Heparin Sodium Product Portfolios and Specifications
Table 99. Pfizer Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments
Table 102. Changshan Biochemical Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 103. Changshan Biochemical Heparin Sodium Product Portfolios and Specifications
Table 104. Changshan Biochemical Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 105. Changshan Biochemical Main Business
Table 106. Changshan Biochemical Latest Developments
Table 107. Aspen Oss Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 108. Aspen Oss Heparin Sodium Product Portfolios and Specifications
Table 109. Aspen Oss Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 110. Aspen Oss Main Business
Table 111. Aspen Oss Latest Developments
Table 112. Opocrin Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 113. Opocrin Heparin Sodium Product Portfolios and Specifications
Table 114. Opocrin Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 115. Opocrin Main Business
Table 116. Opocrin Latest Developments
Table 117. Qingdao Jiulong Biopharmaceutical Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 118. Qingdao Jiulong Biopharmaceutical Heparin Sodium Product Portfolios and Specifications
Table 119. Qingdao Jiulong Biopharmaceutical Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 120. Qingdao Jiulong Biopharmaceutical Main Business
Table 121. Qingdao Jiulong Biopharmaceutical Latest Developments
Table 122. Yino Pharma Limited Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 123. Yino Pharma Limited Heparin Sodium Product Portfolios and Specifications
Table 124. Yino Pharma Limited Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 125. Yino Pharma Limited Main Business
Table 126. Yino Pharma Limited Latest Developments
Table 127. DongyingTiandong Pharmaceutical Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 128. DongyingTiandong Pharmaceutical Heparin Sodium Product Portfolios and Specifications
Table 129. DongyingTiandong Pharmaceutical Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 130. DongyingTiandong Pharmaceutical Main Business
Table 131. DongyingTiandong Pharmaceutical Latest Developments
Table 132. Xinbai Pharmaceuticals Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 133. Xinbai Pharmaceuticals Heparin Sodium Product Portfolios and Specifications
Table 134. Xinbai Pharmaceuticals Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 135. Xinbai Pharmaceuticals Main Business
Table 136. Xinbai Pharmaceuticals Latest Developments
Table 137. LaboratoriosFarmaceuticos ROVI Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 138. LaboratoriosFarmaceuticos ROVI Heparin Sodium Product Portfolios and Specifications
Table 139. LaboratoriosFarmaceuticos ROVI Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 140. LaboratoriosFarmaceuticos ROVI Main Business
Table 141. LaboratoriosFarmaceuticos ROVI Latest Developments
Table 142. Sichuan Deebio Basic Information, Heparin Sodium Manufacturing Base, Sales Area and Its Competitors
Table 143. Sichuan Deebio Heparin Sodium Product Portfolios and Specifications
Table 144. Sichuan Deebio Heparin Sodium Sales (Million Units), Revenue ($ Million), Price (USD/Million Units) and Gross Margin (2020-2025)
Table 145. Sichuan Deebio Main Business
Table 146. Sichuan Deebio Latest Developments
LIST OFFIGURES
Figure 1. Picture of Heparin Sodium
Figure 2. Heparin Sodium Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Heparin Sodium Sales Growth Rate 2020-2031 (Million Units)
Figure 7. Global Heparin Sodium Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Heparin Sodium Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Heparin Sodium Sales Market Share by Country/Region (2024)
Figure 10. Heparin Sodium Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofType A
Figure 12. Product Picture ofType B
Figure 13. Global Heparin Sodium Sales Market Share byType in 2025
Figure 14. Global Heparin Sodium Revenue Market Share byType (2020-2025)
Figure 15. Heparin Sodium Consumed in Standard Heparin Preparation
Figure 16. Global Heparin Sodium Market: Standard Heparin Preparation (2020-2025) & (Million Units)
Figure 17. Heparin Sodium Consumed in Low Molecular Weight Heparin Preparations
Figure 18. Global Heparin Sodium Market: Low Molecular Weight Heparin Preparations (2020-2025) & (Million Units)
Figure 19. Global Heparin Sodium Sale Market Share by Application (2024)
Figure 20. Global Heparin Sodium Revenue Market Share by Application in 2025
Figure 21. Heparin Sodium Sales by Company in 2025 (Million Units)
Figure 22. Global Heparin Sodium Sales Market Share by Company in 2025
Figure 23. Heparin Sodium Revenue by Company in 2025 ($ millions)
Figure 24. Global Heparin Sodium Revenue Market Share by Company in 2025
Figure 25. Global Heparin Sodium Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Heparin Sodium Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Heparin Sodium Sales 2020-2025 (Million Units)
Figure 28. Americas Heparin Sodium Revenue 2020-2025 ($ millions)
Figure 29. APAC Heparin Sodium Sales 2020-2025 (Million Units)
Figure 30. APAC Heparin Sodium Revenue 2020-2025 ($ millions)
Figure 31. Europe Heparin Sodium Sales 2020-2025 (Million Units)
Figure 32. Europe Heparin Sodium Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Heparin Sodium Sales 2020-2025 (Million Units)
Figure 34. Middle East & Africa Heparin Sodium Revenue 2020-2025 ($ millions)
Figure 35. Americas Heparin Sodium Sales Market Share by Country in 2025
Figure 36. Americas Heparin Sodium Revenue Market Share by Country (2020-2025)
Figure 37. Americas Heparin Sodium Sales Market Share byType (2020-2025)
Figure 38. Americas Heparin Sodium Sales Market Share by Application (2020-2025)
Figure 39. United States Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Heparin Sodium Sales Market Share by Region in 2025
Figure 44. APAC Heparin Sodium Revenue Market Share by Region (2020-2025)
Figure 45. APAC Heparin Sodium Sales Market Share byType (2020-2025)
Figure 46. APAC Heparin Sodium Sales Market Share by Application (2020-2025)
Figure 47. China Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 51. India Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Heparin Sodium Sales Market Share by Country in 2025
Figure 55. Europe Heparin Sodium Revenue Market Share by Country (2020-2025)
Figure 56. Europe Heparin Sodium Sales Market Share byType (2020-2025)
Figure 57. Europe Heparin Sodium Sales Market Share by Application (2020-2025)
Figure 58. Germany Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 59.France Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Heparin Sodium Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Heparin Sodium Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Heparin Sodium Sales Market Share by Application (2020-2025)
Figure 66. Egypt Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Heparin Sodium Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Heparin Sodium in 2025
Figure 72. Manufacturing Process Analysis of Heparin Sodium
Figure 73. Industry Chain Structure of Heparin Sodium
Figure 74. Channels of Distribution
Figure 75. Global Heparin Sodium Sales MarketForecast by Region (2026-2031)
Figure 76. Global Heparin Sodium Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Heparin Sodium Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Heparin Sodium Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Heparin Sodium Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Heparin Sodium Revenue Market ShareForecast by Application (2026-2031)
